Join us in Munich in December 2022 to Maximise Commercial Results for Your Biosimilar Products

Join us as we track the latest legal and regulatory ramifications for biosimilar stakeholders. Be part of interactive discussions that will enable you to develop a wholistic legal and regulatory strategy for maximising commercial results for your biosimilar products.

A MUST ATTEND EVENT FOR

Representatives from corporate organisations from functions including:

IP FUNCTIONS:
  • VP Intellectual property
  • Managing Counsel – Patents
  • Head of Biotechnology Unit
  • Patent Attorney
  • IP Director
  • Chief IP Counsel
  • Vice President, Global IP & Litigation
  • Director of Biotech Intellectual Property
LEGAL & REGULATORY FUNCTIONS:
  • Legal Director
  • Biosimilar Business Integrated Program Management
  • International Regulatory Strategy
  • Global Policy & Market Access
  • Portfolio Strategy and Operations
  • Clinical Development – Biosimilars
LEGAL PRACTITIONERS SPECIALISE IN:
  • Intellectual Property and Patent Law/ Litigation
  • Life Sciences
  • Biotechnology
  • Biopharmaceuticals
  • Competition
Testimonial
Quote Icon

If I had to pick only one event to get the latest on issues impacting biosimilars, it would be the C5 Biosimilar Conference — highly informative presentations and ample opportunities to network and catch-up with players in this space.
 

Headshot

Charles K. Sholtz

Director and Associate General Counsel
Biosimilars, Manufacturing & Litigation Readiness Lead

Genentech

WE’RE BACK LIVE AND IN-PERSON
GLOBAL SERIES OF LIFE SCIENCES
Related Conferences
Event Thumbnail Image
Event Thumbnail Image